The biology of IL-23 and IL-17 and their therapeutic targeting in rheumatic diseases

Keyphrases

• Rheumatic Diseases 100%
• Interleukin-17 (IL-17) 100%
• Interleukin-23 (IL-23) 100%
• Therapeutic Targeting 100%
• Rheumatoid Arthritis 50%
• Spondyloarthropathy 50%
• Systemic Lupus Erythematosus 33%
• Immune Cells 33%
• Bone Formation 16%
• Natural History 16%
• Chronic Inflammation 16%
• Immune Response 16%
• Autoimmune Rheumatic Diseases 16%
• Cell-like 16%
• Pathological Role 16%
• Pathogenic Factors 16%
• T Helper 16%
• Structural Damage 16%
• Bona Fide 16%
• Autoinflammatory Conditions 16%
• T Helper 17 (Th17) 16%
• Inflammatory Pathologies 16%
• Biological Therapy 16%
• Innate-like 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Rheumatic Disease 100%
• Interleukin 23 100%
• Interleukin 17 100%
• Cytokine 50%
• Inflammatory Arthritis 50%
• Rheumatoid Arthritis 50%
• Spondyloarthropathy 50%
• Systemic Lupus Erythematosus 33%
• Inflammation 16%
• Chronic Inflammation 16%
• Diseases 16%

Immunology and Microbiology

• Rheumatic Disease 100%
• Interleukin 17 100%
• Interleukin 23 100%
• Inflammatory Arthritis 50%
• Cytokine 50%
• Systemic Lupus Erythematosus 33%
• Immunocompetent Cell 33%
• Autoimmune Rheumatic Disease 16%
• Ossification 16%
• Th17 Cell 16%